BeStock  
Stocks › Biotechnology › GPCR

Structure Therapeutics GPCR

US equityMarket cap rank #2795Biotechnology
$27.59 −$0.08 (-0.29%)
Pre-market · Oct 6, 4:20 am ET · After hours $27.71 +0.43%
Open$28.10
Prev close$27.67
Day range$26.41 – $28.21
Volume1.87M
Market cap$1.97B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$118.63M-68.4% YoY
Net profit-$106.16M-72.2% YoY
Diluted EPS-$1.47-36.1% YoY

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-34.0MSep '24$-36.5MDec '24$-46.8MMar '25$-61.7MJun '25$-65.7MSep '25$33.0MDec '25$-76.0MMar '26$-106.2MJun '26

Diluted EPS by quarter

-0.60Sep '24-0.64Dec '24-0.81Mar '25-1.08Jun '25-1.11Sep '250.47Dec '25-1.05Mar '26-1.47Jun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Other Finance Costs -$12.71M -$13.60M -$35.87M -$9.19M -$8.18M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $118.63M $89.38M $186.81M -$13.74M $73.79M
Selling and Admin Expenses $18.57M $22.87M $61.55M $17.57M $14.80M
-General & Admin Expense $18.57M $22.87M $61.55M $17.57M $14.80M
Research & Development $100.06M $66.51M $225.26M $68.69M $58.99M
Operating Profit -$118.63M -$89.38M -$186.81M $13.74M -$73.79M
Net Non-Operating Interest Income (Expense) $12.71M $13.60M $35.87M $9.19M $8.18M
Diluted EPS -$1.47 -$1.05 -$2.40 $0.47 -$1.11
Pretax Profit -$105.93M -$75.78M -$140.69M $33.17M -$65.60M
Basic EPS -$1.47 -$1.05 -$2.40 $0.47 -$1.11
Net Income to Common Stockholders -$106.16M -$75.97M -$141.20M $33.00M -$65.71M
Net Income to Parent Company -$106.16M -$75.97M -$141.20M $33.00M -$65.71M
Profit from Continuing Operations -$106.16M -$75.97M -$141.20M $33.00M -$65.71M
Net Profit -$106.16M -$75.97M -$141.20M $33.00M -$65.71M
Tax $234,000.00 $190,000.00 $515,000.00 $170,000.00 $108,000.00
Special Income (Charges) – – $10.25M – –
-Gain on Sale of Property/Plant/Equipment – – $10.25M – –
Other Income (Expense) – – $10.25M – –
Other Operating Expenses – – -$100.00M – –

Discussion

No comments yet — be the first to weigh in on GPCR.

Leave a comment

Scroll to Top